Related Experiment Video
Updated: May 19, 2026

09:57
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review
Sorina Nicoleta Badelita1, Horia Mihail Sandu1, Daniel Coriu1,2
1Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania.
Frontiers in Oncology
|May 18, 2026
Abstract:
Bone marrow hemodilution could compromise next generation flow cytometry based measurable residual disease evaluation in multiple myeloma and may cause false negative results. This review summarizes definitions, markers, indices, mitigation strategies, and current challenges in standardization.

